| 1 Occurrence of AIDS‐related events |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 1.1 SPV30 versus placebo |
1 |
145 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.12 [0.01, 1.08] |
| 2 CD4 cell count less than 20 millions per litre |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 2.1 SPV30 versus placebo |
1 |
145 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.74 [0.33, 1.69] |
| 3 Overall health perception (no. improved) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 3.1 IGM‐1 (Chinese herbs) versus placebo |
1 |
30 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.20, 2.79] |
| 4 CD4 cell count ( X 10 6/L) |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 4.1 SPV30 (990 mg/day) versus placebo |
1 |
96 |
Mean Difference (IV, Fixed, 95% CI) |
39.70 [‐14.00, 95.40] |
| 4.2 SPV30 (1980 mg/day) versus placebo |
1 |
97 |
Mean Difference (IV, Fixed, 95% CI) |
16.0 [‐35.12, 67.12] |
| 4.3 Chinese medicinal herbs versus placebo |
1 |
68 |
Mean Difference (IV, Fixed, 95% CI) |
‐80.0 [‐183.25, 23.25] |
| 5 Viral load (log unit or copies/ml) |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 5.1 SPV30 (990 mg/day) versus placebo |
1 |
77 |
Mean Difference (IV, Fixed, 95% CI) |
0.11 [‐0.22, 0.44] |
| 5.2 SPV30 (1980 mg/day) versus placebo |
1 |
79 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.15 [‐0.49, 0.19] |
| 5.3 Chinese medicinal herbs versus placebo |
1 |
68 |
Mean Difference (IV, Fixed, 95% CI) |
20117.0 [‐29673.20, 69907.20] |
| 5.4 Qiankunning versus placebo |
1 |
36 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.16 [‐0.52, 0.20] |
| 6 Overall life satisfaction |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 6.1 IGM‐1 (Chinese herbs) versus placebo |
1 |
30 |
Mean Difference (IV, Fixed, 95% CI) |
0.66 [0.05, 1.27] |
